With respect to age, gender, treatment at the time of sampling, primary site, with or without surgery, existence of lymph node metastasis, and CEA level, there were no significant differences between the two groups (Table 2). This evidence concerns the gene CEACAM5 and metastatic malignant neoplasm in the lymph nodes.